Fig. 7From: Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammationSchematic diagram of Resatorvid on cartilage degradation and synovitis during TMJOA. Resatorvid mitigates synovial inflammation and cartilage degradation during TMJOA through alleviating ROS-mediated proinflammatory cytokine secretion from macrophages, pyroptosis, and chondrocyte degeneration via the TLR4/MyD88/NF-κB/NLRP3 signaling pathwayBack to article page